MicroRNA-15a Inhibits Glucose Transporter 4 Translocation and Impairs Glucose Metabolism in L6 Skeletal Muscle Via Targeting of Vesicle-Associated Membrane Protein-Associated Protein A-Reference-Cited by-同舟云学术

MicroRNA-15a Inhibits Glucose Transporter 4 Translocation and Impairs Glucose Metabolism in L6 Skeletal Muscle Via Targeting of Vesicle-Associated Membrane Protein-Associated Protein A

Published:2020-04 Issue:3 Volume:44 Page:261-266.e2
ISSN:1499-2671
Container-title:Canadian Journal of Diabetes
language:en
Short-container-title:Canadian Journal of Diabetes

Author:

Guo Ying,Li Gang,Li Huiqing,Huang Chunlan,Liu Qiao,Dou Yifei,Yin Xiurong,Dong Lixia,Yang Na,Han Zhonghou

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference22 articles.

1. Epigenetic regulation of glucose metabolism;Sharma;Curr Opin Clin Nutr Metab Care,2017

2. Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus;Petersen;Am J Cardiol,2002

3. A functional role for VAP-A in insulin-stimulated GLUT4 traffic;Foster;Traffic,2000

4. Insight into miRNAs related with glucometabolic disorder;Zhang;Biomed Pharmacother,2019

5. Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strain of human malignant epithelial cells (strain HeLa) derived from an epidermoid carcinoma of the cervix;Scherer;J Exp Med,1953

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significant role of some miRNAs as biomarkers for the degree of obesity;Journal of Genetic Engineering and Biotechnology;2023-12

2. Glucose transporter 4: Insulin response mastermind, glycolysis catalyst and treatment direction for cancer progression;Cancer Letters;2023-06

3. Mitochondrial dynamics related neurovascular approaches in cerebral ischemic injury;Mitochondrion;2022-09

4. Differences in liver microRNA profiling in pigs with low and high feed efficiency;Journal of Animal Science and Technology;2022-03

5. miR-140-5p Aggravates Insulin Resistance via Directly Targeting GYS1 and PPP1CC in Insulin-Resistant HepG2 Cells;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2021-06